Deals & Cases

Davis Polk advised the sales agent in connection with Revolution Medicines' SEC-registered at-the-market offering of common stock for up to $1 billion...

Trowers & Hamlins advised on the £6.25m first close for Greater Cambridge Impact (GCI), enabling the initiative to move from development to delivery....

Cleary Gottlieb represented EG On The Move in its acquisition of EG Group’s portfolio of approximately 260 forecourt sites in France. The transactio...

Orrick Herrington & Sutcliffe advised Axelera AI on a funding round exceeding $250 million — the largest investment in an EU AI semiconductor compan...

Cravath, Swaine & Moore LLP represented The Walt Disney Company in a $4 billion registered notes offering that closed on February 12, 2026. The Walt D...

Paul Weiss advised KKR in connection with OSTTRA on a strategic equity investment by Bank of America, Barclays, Citi, HSBC, UBS Investment Bank and We...

Proskauer advised Sixth Street on a senior secured credit facility of up to $500 million with Beam Therapeutics Inc., providing long-term, non-dilutiv...

Davis Polk advised Mitsubishi HC Finance America LLC and Mitsubishi HC Capital Inc. on a $500 million Rule 144A/Regulation S offering of 4.558% senior...

Davis Polk advised the representatives of the several underwriters in connection with Synchrony Financial’s SEC-registered offering of $750 million ...

Khaitan & Co has requested withdrawal of a deal report concerning its advice to Hillhouse Investment Management on a minority investment in Quest Glob...

Khaitan & Co advised Numaligarh Refinery Limited on drafting and finalisation of the tender suite and green hydrogen purchase agreement. NeuEN Green E...

Khaitan & Co advised Kotak Life Sciences Fund I and Alkemi Venture Fund II Scheme I on their primary investment in Zeroharm Sciences Private Limited, ...